Trade Names: | |
Synonyms: | |
Status: | Approved (1985) |
Entry Type: | Small molecule |
Molecule Category: | UNKNOWN |
ATC: | A04AD11 |
UNII: | 2N4O9L084N |
InChI Key | GECBBEABIDMGGL-UHFFFAOYSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C24H36O3 |
Molecular Weight | 372.55 |
AlogP | 6.26 |
Hydrogen Bond Acceptor | 3.0 |
Hydrogen Bond Donor | 1.0 |
Number of Rotational Bond | 6.0 |
Polar Surface Area | 46.53 |
Molecular species | NEUTRAL |
Aromatic Rings | 1.0 |
Heavy Atoms | 27.0 |
Action | Mechanism of Action | Reference |
---|---|---|
AGONIST | Cannabinoid CB1 receptor agonist | DailyMed |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Lipid-like ligand receptor (family A GPCR)
Cannabinoid receptor
|
16 | - | - | 4 | - |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Postoperative Nausea and Vomiting | 4 | D020250 | ClinicalTrials |
Postoperative Nausea and Vomiting | 4 | D020250 | ClinicalTrials |
Diabetic Neuropathies | 3 | D003929 | ClinicalTrials |
Parkinson Disease | 3 | D010300 | ClinicalTrials |
Muscle Spasticity | 2 | D009128 | ClinicalTrials |
Obesity | 2 | D009765 | ClinicalTrials |
Suicidal Ideation | 2 | D059020 | ClinicalTrials |
Fibromyalgia | 2 | D005356 | ClinicalTrials |
Marijuana Abuse | 2 | D002189 | ClinicalTrials |
Neuralgia | 2 | D009437 | ClinicalTrials |
Obsessive-Compulsive Disorder | 1 | D009771 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 51022-71-0 |
ChEBI | 135574 |
ChEMBL | CHEMBL2218896 |
DrugBank | DB00486 |
DrugCentral | 1862 |
FDA SRS | 2N4O9L084N |
Guide to Pharmacology | 9071 |
KEGG | D05099 |
PubChem | 5284592 |
SureChEMBL | SCHEMBL563809 |
ZINC | ZINC01542930 |